Efficacy and Safety Study of Autonomic Nerve Modulation (ANM) in Subjects With Moderate Plaque Psoriasis
Clinical trial NCT03817164 · UNKNOWN
Trial details
- NCT number
- NCT03817164
- Sponsor
- Thync Global, Inc.
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-02
- Primary completion
- 2019-10-30
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.